LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.00043333
 23.10 84.90 1364 1616 0.8440 0.9217
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 23.10 84.90 1616 1616 0.9999 0.9999
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 24.81 84.90 1790 1769 1.0116 1.0053
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 24.81 84.90 1928 1769 1.0896 1.0395
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 24.81 84.90 1558 1769 0.8805 0.9427
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 24.81 84.90 1773 1769 1.0020 1.0009
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 26.51 84.90 1930 1923 1.0036 1.0016
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 26.51 84.90 2065 1923 1.0737 1.0319
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 26.51 84.90 1768 1923 0.9193 0.9630
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 26.51 84.90 1925 1923 1.0010 1.0004
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 28.21 84.90 1985 2091 0.9491 0.9775
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 28.21 84.90 2239 2091 1.0705 1.0297
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 28.21 84.90 1950 2091 0.9323 0.9699
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 28.21 84.90 2100 2091 1.0041 1.0018
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 29.92 84.90 2327 2237 1.0399 1.0166
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 29.92 84.90 2435 2237 1.0882 1.0361
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 29.92 84.90 2144 2237 0.9581 0.9820
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 29.92 84.90 2250 2237 1.0055 1.0023
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 31.62 84.90 2523 2449 1.0299 1.0122
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 31.62 84.90 2626 2449 1.0720 1.0289
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 31.62 84.90 2313 2449 0.9442 0.9765
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 31.62 84.90 2427 2449 0.9907 0.9962
MN20160318_Q02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 33.32 84.90 2786 2722 1.0234 1.0093
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 33.32 84.90 2866 2722 1.0527 1.0207
MN20160318_Q02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 33.32 84.90 2566 2722 0.9426 0.9765
MN20160318_Q02
H08